Navigo Proteins GmbH

https://www.navigo-proteins.com

Navigo Proteins is a premier protein engineering company, discovering, and developing Precision Affinity Ligands. Precision Affinity Ligands are based on small, stable, and highly engineerable scaffold proteins and are functionalized for two different applications: As targeted next-gen therapeutics (PRECISION TARGETING); and for custom affinity purification of biologics (PRECISION CAPTURING®). Under the Precision Targeting Business Unit, Navigo is developing next-generation targeted therapeutics. Leveraging its long-standing expertise in protein engineering and drug design, Navigo develops Affilin® ligands using a state-of-the-art, fully automated, high throughput screening and selection technology employing large, ubiquitin-based libraries. Affilin® molecules can be customized as mono, bi-/ or multi-specific ligands which can be further coupled to various functional moieties like cytotoxic payloads and radioactive isotopes. With a clear focus in precision oncology and a drive to bring innovative, best-in-class therapies to patients, Navigo is developing novel Affilin® against Tumor Associated Antigens (TAAs) as well as immuno-oncology (I/O) targets. With a growing portfolio of Affilin® assets, and excellent pre-clinical data from in-house and partnered projects, Navigo is primed to advance Affilin®-based biopharmaceuticals into clinical development. *

	Start	2017-02-03 renamed
	Group	UV-Cap (Vetter family office) (Group)
	Predecessor	Scil Proteins GmbH
	Industry	BIOTECH
	Person	Afflerbach, Henning (Coral BioNet 201205 CBO at Scil Proteins)
	Person 2	Vetter, Udo J. (UV-Cap 201702 Founder + Managing Director)

	Region	Halle (Saale)
	Country	Germany
	Street	1 Heinrich-Damerow-Str.
	City	06120 Halle (Saale)
	Tel	+49-345-27996-330
		Address record changed: 2022-09-26

Basic data	Employees	C: 51 to 100 (2011-02-18)

		* Document for »About Section«: Navigo Proteins GmbH. (9/6/23). "Press Release: Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin Ligand Discovery Using Cutting-edge AI and Molecular Modeling Techniques". Halle (Saale) & Barcelona.

		Record changed: 2023-12-30